Rallybio Corp (RLYB)

Finanzdaten der Rallybio Corp-Aktie (RLYB)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	6.28% 19.79	21.11	19.36	20.08	18.37
Depreciation and Amortization	2.78% 0.035	0.036	0.037	0.038	0.039
Operating Income/Loss	6.28% -19.79	-21.11	-19.36	-20.08	-18.37
Nonoperating Income/Loss	2.70% 1.443	1.483	1.637	1.67	1.619
Income/Loss Before Equity Method Investments	6.55% -18.34	-19.63	-17.73	-18.41	-16.75
Income/Loss From Equity Method Investments	11.75% -0.685	-0.613	-0.648	-0.217	-0.563
Income/Loss From Continuing Operations Before Tax	6.55% -18.34	-19.63	-17.73	-18.41	-16.75
Income/Loss From Continuing Operations After Tax	6.55% -18.34	-19.63	-17.73	-18.41	-16.75
Net Income/Loss	5.99% -19.03	-20.24	-18.37	-18.63	-17.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	62,858% 40.77	0.0648	40.53	40.36	40.25
Diluted Average Shares	62,858% 40.77	0.0648	40.53	40.36	40.25
Basic Earnings Per Share	4.08% -0.47	-0.49	-0.45	-0.46	-0.43
Diluted Earnings Per Share	4.08% -0.47	-0.49	-0.45	-0.46	-0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-